{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:16:58Z","timestamp":1715300218296},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.2169\/internalmedicine.8746-21","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T22:09:29Z","timestamp":1639778969000},"page":"2061-2065","source":"Crossref","is-referenced-by-count":1,"title":["Nephrotic Syndrome and Atypical Posterior Reversible Encephalopathy Syndrome in a Patient with Parkinson's Disease"],"prefix":"10.2169","volume":"61","author":[{"given":"Ryo","family":"Tokimura","sequence":"first","affiliation":[{"name":"Department of Neurology, National Hospital Organization Fukushima National Hospital, Japan"},{"name":"Department of Neurology, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Fukushima National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Fukushima National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ugawa","sequence":"additional","affiliation":[{"name":"Department of Human Neurophysiology, Fukushima Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Blaise AS, Baille G, Carri\u00e8re N, et al. Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: a large single-center study. Rev Neurol (Paris) 176: 268-276, 2020.","DOI":"10.1016\/j.neurol.2019.07.024"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kodner C. Diagnosis and management of nephrotic syndrome in adults. Am Fam Physician 93: 479-485, 2016.","DOI":"10.1007\/978-3-662-52972-0_17"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14: 914-925, 2015.","DOI":"10.1016\/S1474-4422(15)00111-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189: 904-912, 2007.","DOI":"10.2214\/AJR.07.2024"},{"key":"5","doi-asserted-by":"crossref","first-page":"e020821","DOI":"10.1136\/bmjopen-2017-020821","volume":"8","author":"ZH Huang","year":"2018","unstructured":"5. Huang ZH, Chen HC, Chou YC, et al. Does nephrotic syndrome without chronic kidney disease increase the risk of Parkinson's disease and secondary parkinsonism? A nationwide population-based study in Taiwan. BMJ Open 8: e020821, 2018.","journal-title":"BMJ Open","ISSN":"http:\/\/id.crossref.org\/issn\/2044-6055","issn-type":"print"},{"key":"6","unstructured":"6. Heras M, S\u00e1iz A, Fern\u00e1ndez-Reyes MJ, et al. Spontaneous remission of nephrotic syndrome in a patient with diabetic nephropathy and Parkinson's disease. Nefrologia 31: 368-369, 2011."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chaitanya VB, Sangeetha B, Rao VN, Ram R, Vengamma B, Kumar VS. Membranous nephropathy associated with the use of levodopa-carbidopa combination. Indian J Nephrol 25: 127-128, 2015.","DOI":"10.4103\/0971-4065.145130"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Higashino M, Endo K, Rinno S, et al. A case of amantadine in a patient with nephrotic syndrome and an acute kidney injury. Tousekikaishi (J Jpn Soc Dial Ther) 53: 271-277, 2020 (in Japanese).","DOI":"10.4009\/jsdt.53.271"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Utsumi K, Amemiya S, Iizuka M, Iino Y, Katayama Y. Acute posterior leukoencephalopathy in a patient with nephrotic syndrome. Clin Exp Nephrol 7: 63-66, 2003.","DOI":"10.1007\/s101570300009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Aksoy DY, Arici M, Kiykim AA, et al. Posterior leukoencephalopathy and nephrotic syndrome: just a coincidence? Am J Med Sci 327: 156-159, 2004.","DOI":"10.1097\/00000441-200403000-00008"},{"key":"11","unstructured":"11. Looi JL, Christiansen JP. Reversible posterior leukoencephalopathy associated with minimal change nephrotic syndrome. N Z Med J 119: U2257, 2006."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. de Oliveira RA, Fechine LM, Neto FC, Nicodemus JM, Silva GB Jr, Silva LS. Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis. Int Urol Nephrol 40: 1095-1098, 2008.","DOI":"10.1007\/s11255-008-9431-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nabi Z, Al Korbi L, Ghailani M, Nadri Q, Abdelsalam M, Al Baqumi M. Reversible posterior leukoencephalopathy syndrome in a patient of FSGS with heavy proteinuria. Ren Fail 32: 892-894, 2010.","DOI":"10.3109\/0886022X.2010.494794"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chowdhary M, Kabbani AA, Tobey D, Hope TD. Posterior reversible encephalopathy syndrome in a woman with focal segmental glomerulosclerosis. Neuropsychiatr Dis Treat 11: 1111-1114, 2015.","DOI":"10.2147\/NDT.S84010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chang MY, Tsai BM, Hung SY, et al. Posterior reversible encephalopathy syndrome in an adult with nephrotic syndrome. Nephrology (Carlton) 19: 514-515, 2014.","DOI":"10.1111\/nep.12275"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Miaris N, Maltezou M, Papaxoinis G, Visvikis A, Samantas E. Posterior reversible encephalopathy syndrome with concurrent nephrotic syndrome in a patient treated with pazopanib for metastatic renal cell carcinoma: case report and review of the literature. Clin Genitourin Cancer 15: e99-e103, 2017.","DOI":"10.1016\/j.clgc.2016.08.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Li KY, Chien CF, Tsai CL, et al. Infection-provoked reversible posterior leukoencephalopathy syndrome in an adult with nephrotic syndrome: a case report. BMC Neurol 20: 349, 2020.","DOI":"10.1186\/s12883-020-01922-x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/13\/61_8746-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:16:26Z","timestamp":1715231786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/13\/61_8746-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":17,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8746-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"8746-21"}}